Drugs Approved for Liver Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for liver cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in liver cancer that are not listed here.
Drugs Approved for Liver Cancer
- Atezolizumab
- Atezolizumab and Hyaluronidase-tqjs
- Avastin (Bevacizumab)
- Bevacizumab
- Cabometyx (Cabozantinib-S-Malate)
- Cabozantinib-S-Malate
- Cyramza (Ramucirumab)
- Durvalumab
- Futibatinib
- Imfinzi (Durvalumab)
- Imjudo (Tremelimumab-actl)
- Ipilimumab
- Keytruda (Pembrolizumab)
- Lenvatinib Mesylate
- Lenvima (Lenvatinib Mesylate)
- Lytgobi (Futibatinib)
- Nexavar (Sorafenib Tosylate)
- Nivolumab
- Opdivo (Nivolumab)
- Pemazyre (Pemigatinib)
- Pembrolizumab
- Pemigatinib
- Ramucirumab
- Regorafenib
- Sorafenib Tosylate
- Stivarga (Regorafenib)
- Tecentriq (Atezolizumab)
- Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)
- Tremelimumab-actl
- Yervoy (Ipilimumab)